CDC Predicts NB.1.8.1 COVID Variant Could Represent a Third of U.S. Cases

CDC Predicts NB.1.8.1 COVID Variant Could Represent a Third of U.S. Cases

The newly emerged NB.1.8.1 COVID-19 strain, which has been associated with a significant spike in hospital admissions in Asia, is now thought to account for more than one-third of cases in the U.S., according to recent data from the Centers for Disease Control and Prevention (CDC).

In the previous month, the CDC's program monitoring airports identified instances of this variant among travelers arriving from different countries. The agency noted that NB.1.8.1 comprised nearly half of the COVID cases detected in this surveillance during the last week of May.

While precision levels in the latest reports are low, implying a wide error margin, the CDC's findings underscore a notable rise in the variant's prevalence. This increase hints at the variant's high rate of transmission—a concern previously voiced by health experts when it first emerged in the country.

"Even though NB.1.8.1 does not seem to cause more severe sickness compared to older variants, its rapid spread suggests it's more easily transmitted," explained Subhash Verma, a professor of microbiology and immunology at the University of Nevada, Reno School of Medicine.

Verma added that the symptoms of this variant are largely similar to past strains, including respiratory problems such as a cough and sore throat, alongside general symptoms like fever and fatigue.

While the virus continues to be monitored by health authorities, the current U.S. administration under Trump has initiated changes affecting vaccine availability for some segments of the population.

In May, federal decisions ensured continued approval of COVID-19 vaccine updates specifically for the elderly and those with health conditions like pregnancy or diabetes. However, vaccine manufacturers are required to execute comprehensive clinical trials before offering these vaccines more broadly.

Consequently, individuals without these underlying health issues may not access new vaccine versions this coming autumn.

Last month, the Secretary of Health and Human Services announced his intent to eliminate the CDC's recommendation for certain groups to receive the COVID-19 vaccine. Nevertheless, the CDC later affirmed that children without health conditions could still receive the vaccination, based on parental preference and advice from healthcare providers.

"If a parent wishes for their child, aged six months and above, to be vaccinated, this can proceed guided by medical professional judgment and personal choice," the CDC advises in its revised guidance.

About the Pandemic

Sara Moniuszko, a journalist at CBSNews.com, specializes in health and lifestyle reporting. She previously contributed to USA Today, assisting in launching their wellness content category. Currently, Moniuszko is focused on delivering news on rising and urgent health matters for CBS News' HealthWatch.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts